Clinical trials recruiting in Izunokuni, Japan

Phase breakdown

Conditions recruiting in Izunokuni, Japan

Recruiting trials in Izunokuni, Japan

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
  NCT07165028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
  NCT05392764 · Phase: Phase 3 · Ages: 20 Years and older · Sex: All (male and female)
• Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
  NCT07397650 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
  NCT04796350 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 91 Years · Sex: Female

Common questions

How many clinical trials are recruiting in Izunokuni, Japan?

4 recruiting trials have at least one study site in Izunokuni, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.